These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2864141)

  • 21. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
    Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GP-45795: a controlled evaluation in chronic schizophrenic patients.
    Gallant DM; Bishop MP; Guerrero-Figueroa R
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):215-9. PubMed ID: 4623600
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and experimental study of oxyprothepine.
    Zapletálek M; Zbytovský J; Kindernayová H
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(4):487-90. PubMed ID: 6111116
    [No Abstract]   [Full Text] [Related]  

  • 24. GP-45795: A new dibenzothiepin antipsychotic agent.
    Gallant DM; Guerrero-Figueroa R; Bishop MP
    Curr Ther Res Clin Exp; 1971 Jul; 13(7):469-72. PubMed ID: 5000301
    [No Abstract]   [Full Text] [Related]  

  • 25. Results of maintenance therapy with oxyprothepin decanoate in schizophrenics: open study.
    Svestka J; Náhunek K; Cesková E; Rysánek R
    Act Nerv Super (Praha); 1979 Oct; 21(3):138-9. PubMed ID: 42261
    [No Abstract]   [Full Text] [Related]  

  • 26. Three cases of alopecia areata induced by zotepine.
    Kubota T; Ishikura T; Jibiki I
    Acta Neurol (Napoli); 1993 Jun; 15(3):200-3. PubMed ID: 7901970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxyprothepin and clorotepin compared in the hyperkinetic syndrome.
    Výborová L; Náhunek K; Drtilková I; Balastíková B
    Act Nerv Super (Praha); 1989 Apr; 31(1):45-6. PubMed ID: 2571227
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical experience with octoclothepin.
    Rydzyński Z; Wierzbicki T
    Act Nerv Super (Praha); 1970 Jan; 12(1):46-7. PubMed ID: 5418655
    [No Abstract]   [Full Text] [Related]  

  • 29. Results of a multicenter AMDP study with fluperlapine in schizophrenic patients.
    Woggon B; Heinrich K; Küfferle B; Müller-Oerlinghausen B; Pöldinger W; Rüther E; Schied HW
    Arzneimittelforschung; 1984; 34(1A):122-4. PubMed ID: 6145427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the short-term therapeutic effect of oxyprothepine and perphenazine in schizophrenic patients. A controlled study.
    Svestka J; Rodovà A; Nàhunek K
    Act Nerv Super (Praha); 1973 May; 15(2):103-4. PubMed ID: 4591602
    [No Abstract]   [Full Text] [Related]  

  • 31. An uncontrolled clinical study with EX 11-582A in the treatment of chronic schizophrenic patients.
    Lehmann HE; Ban TA; Deutsch M
    Psychopharmacol Bull; 1977 Jul; 13(3):7-9. PubMed ID: 18761
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R; Kabesh Ia; Papezhova G
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia].
    Matkowski K; Sep-Kowalikowa B
    Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095
    [No Abstract]   [Full Text] [Related]  

  • 35. Zotepine in the treatment of acute hospitalized schizophrenic episodes.
    Kasper S; Quiner S; Barnas C; Fabisch H; Haushofer M; Sackel C; König P; Lingg A; Platz T; Rittmannsberger H; Stuppäck C; Willeit M; Zapotoczky HG
    Int Clin Psychopharmacol; 2001 May; 16(3):163-8. PubMed ID: 11354238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled comparison of therapeutic effects of oxyprothepin and chlorpromazine in schizophrenic patients [proceedings].
    Vinar O; Taussigová D; Bastecký J; Vinarová E
    Act Nerv Super (Praha); 1976; 18(3):212-4. PubMed ID: 12642
    [No Abstract]   [Full Text] [Related]  

  • 37. Zotepine: a clinical review.
    Green B
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):181-6. PubMed ID: 19199377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperlipidemia--side-effect of the treatment with an atypical antipsychotic (zotepine)?].
    Wetterling T
    Psychiatr Prax; 2002 Nov; 29(8):438-40. PubMed ID: 12436365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zotepine-induced convulsion at a low dose in a case of paranoid schizophrenia.
    Ali M; Das S
    Psychiatry Clin Neurosci; 2018 May; 72(5):374. PubMed ID: 29363876
    [No Abstract]   [Full Text] [Related]  

  • 40. Perathiepine in psychiatry: search for its indications.
    Vinar O; Ledererová E; Bastecký J
    Act Nerv Super (Praha); 1967 Nov; 9(4):429-30. PubMed ID: 4889079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.